Skip to main content
Clinical Trials/NL-OMON50860
NL-OMON50860
Completed
N/A

Exploratory study into age-related immunological differences related to immunogenicity in influenza vaccination and herpes zoster vaccination - INFLUENZA-SHINGRIX

Radboud Universitair Medisch Centrum0 sites147 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Radboud Universitair Medisch Centrum
Enrollment
147
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
May 17, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age between 18\-35 years old OR age \>\=65 years old
  • Written informed consent

Exclusion Criteria

  • Known allergy to (components of) the influenza or herpes zoster vaccine
  • Immunocompromised subjects
  • Previous herpes zoster vaccination in the last year
  • Receipt of any vaccination 4 weeks prior to the start of the study or plans
  • to receive any other vaccination until 2 months after inclusion
  • Chronic use of systemic drugs other than oral contraceptives
  • Use of NSAIDS less than 4 weeks prior to the start of the study
  • Acute or active illness within two weeks prior to the start of the study
  • Pregnant, breastfeeding or planning to become pregnant during the study

Outcomes

Primary Outcomes

Not specified

Similar Trials